Betahistine Does Not Work for Acute BPPV and Should Not Be Used
Betahistine has no role in the acute treatment of BPPV—the definitive treatment is canalith repositioning procedures (Epley or Semont maneuvers), not medications. The 2017 AAO-HNS clinical practice guideline explicitly states that "medications are not used other than for relief of immediate distress, such as nausea" 1. This is the highest quality evidence available and should guide your practice.
Why Betahistine Doesn't Work for BPPV
BPPV is a mechanical problem caused by displaced otoconia (calcium crystals) in the semicircular canals 1. The pathophysiology involves free-floating particles that abnormally stimulate the vestibular apparatus when you change head position. No medication can reposition these crystals—only physical maneuvers can.
The mechanism of betahistine (a weak H1 agonist and strong H3 antagonist) involves improving blood flow to the inner ear and modulating vestibular compensation 2, 3. While this may theoretically help with other vestibular disorders like Ménière's disease, it doesn't address the mechanical displacement of crystals in BPPV.
What the Research Actually Shows
The evidence on betahistine for BPPV is contradictory and ultimately unconvincing:
A 2025 meta-analysis found betahistine added to Epley maneuver showed NO clinically significant difference in DHI scores, VAS scores, or provocation maneuvers after 1 week. Only after 4 weeks was there a statistically significant (but questionably clinical) reduction in VAS scores 4.
A 2023 study found NO difference between Epley alone versus Epley plus betahistine for dizziness or anxiety symptoms 5.
A 2016 Cochrane review rated the evidence for betahistine in vertigo as LOW QUALITY overall, with high heterogeneity and risk of bias 6.
The most recent high-quality evidence (2025) shows betahistine adds nothing meaningful in the acute phase 4.
What You Should Actually Do
For Acute BPPV:
Diagnose with Dix-Hallpike test (for posterior canal BPPV, 85-95% of cases) or supine roll test (for lateral canal BPPV) 1
Treat immediately with canalith repositioning procedures:
- Epley maneuver for posterior canal BPPV
- Success rate ~80% with 1-3 treatments 1
For immediate symptom relief during the maneuver: Consider antiemetics for nausea only—not vestibular suppressants 1
Do NOT prescribe betahistine for acute treatment
Common Pitfalls to Avoid:
Don't order brain imaging unless there are red flags for central causes (this is resource-wasteful and exposes patients to unnecessary radiation) 7
Don't prescribe meclizine or other vestibular suppressants—these are ineffective for BPPV and have side effects 7
Don't use betahistine as first-line therapy—it doesn't address the mechanical problem
When Betahistine Might Have a Limited Role:
The only potential (and still questionable) use is for residual dizziness after successful repositioning, where some evidence suggests it may help with vestibular compensation over weeks 3, 8. However, even this indication is not strongly supported and should not be routine practice.
The bottom line: BPPV has an 80% cure rate with a simple bedside maneuver that takes minutes 1. Using betahistine instead of or before performing repositioning maneuvers is suboptimal care that delays definitive treatment and exposes patients to unnecessary medication side effects.